Your browser doesn't support javascript.
loading
A case report of a cystic fibrosis patient with repeated isolation of Trichosporon mycotoxinivorans identified by a novel short-extraction method.
Goldenberger, Daniel; Hinic, Vladimira; Prince, Spasenija Savic; Tamm, Michael; Balestra, Anna-Maria; Hohler, Doris; Frei, Reno.
Afiliação
  • Goldenberger D; Division of Clinical Microbiology, University Hospital Basel, Petersgraben 4, CH-4031, Basel, Switzerland. daniel.goldenberger@usb.ch.
  • Hinic V; Division of Clinical Microbiology, University Hospital Basel, Petersgraben 4, CH-4031, Basel, Switzerland.
  • Prince SS; Division of Pathology, University Hospital Basel, Schönbeinstrasse 40, CH-4031, Basel, Switzerland.
  • Tamm M; Division of Pneumology, University Hospital Basel, Petersgraben 4, CH-4031, Basel, Switzerland.
  • Balestra AM; Division of Pneumology, University Hospital Basel, Petersgraben 4, CH-4031, Basel, Switzerland.
  • Hohler D; Present address: Division of Pneumology, St. Claraspital Basel, Basel, Switzerland.
  • Frei R; Division of Clinical Microbiology, University Hospital Basel, Petersgraben 4, CH-4031, Basel, Switzerland.
BMC Infect Dis ; 16(1): 601, 2016 Oct 25.
Article em En | MEDLINE | ID: mdl-27782810
ABSTRACT

BACKGROUND:

Trichosporon mycotoxinivorans is a recently described yeast-like fungal organism and its association as a pathogen for patients with cystic fibrosis (CF) was reported previously. We show the clinical course of a CF patient over 9 years as well as the applications of modern molecular and proteomic identification techniques of this rare fungus. CASE PRESENTATION We present the case of a 32-year-old male CF patient with sputum cultures continuously positive with the anamorphic yeast T. mycotoxinivorans during 9 years. Furthermore, susceptibility testing of T. mycotoxinivorans to different antifungals were performed. In addition, a rapid identification method of this novel fungal pathogen with matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) was applied using a simple extraction protocol.

CONCLUSIONS:

Our case presentation confirms T. mycotoxinivorans as a potential emerging pathogen in patients with CF. However, our CF patient showed mild symptoms over a very long time period of 9 years. A short MALDI-TOF MS procedure allows reliable and rapid identification of T. mycotoxinivorans and therefore should facilitate further study on the clinical relevance and epidemiology of this unusual fungal organism.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trichosporon / Fibrose Cística Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trichosporon / Fibrose Cística Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article